Showing results (1771-1780 of 1,866) with videos related to

Sort By:
Pageof 187
Eclinicalmedicine|July 29, 2025
Dynamic versus fixed cerebral perfusion pressure targets in paediatric traumatic brain injury: a STARSHIP analysisC A Smith, S Y Bögli, M M Placek, et al.
Frontiers in Pharmacology|October 11, 2021
<i>Bifidobacterium</i> Strains Present Distinct Effects on the Control of Alveolar Bone Loss in a Periodontitis Experimental ModelNatali Shimabukuro, Amália C de S Cataruci, Karin H Ishikawa, et al.
Breast Cancer Research and Treatment|April 28, 2017
Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA.32Ana Elisa Lohmann, Mira F Liebman, William Brien, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2019
A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB)Ingrid A Mayer, Aleix Prat, Daniel Egle, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|April 24, 2026
High-Altitude Exercise Performance and Acute Mountain Sickness Unchanged Following Cold Water HabituationAfton D Seeley, Thomas A Mayer, Billie K Alba, et al.
Neurocritical Care|May 24, 2019
Common Data Elements for Unruptured Intracranial Aneurysms and Aneurysmal Subarachnoid Hemorrhage: Recommendations from the Working Group on Hospital Course and Acute Therapies-Proposal of a Multidisciplinary Research GroupAirton Leonardo de Oliveira Manoel, Mathieu van der Jagt, Sepideh Amin-Hanjani, et al.
Journal of the National Cancer Institute|March 6, 2015
Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32Pamela J Goodwin, Wendy R Parulekar, Karen A Gelmon, et al.
Journal of Neurotrauma|June 11, 2015
A Consensus-Based Interpretation of the Benchmark Evidence from South American Trials: Treatment of Intracranial Pressure TrialRandall M Chesnut, Thomas P Bleck, Giuseppe Citerio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 24, 2019
A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancerJ Veeraraghavan, C De Angelis, R Mao, et al.
Breast Cancer Research and Treatment|July 5, 2024
A randomized phase III double-blind placebo-controlled trial of first-line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)Jessica Mezzanotte-Sharpe, Anne ONeill, Ingrid A Mayer, et al.
Pageof 187